TotalMarketCap

Edesa Biotech

EDSANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$28.898 M

$2.14 -1.38%

Close of 6 Nov 2026

As of 6 Nov 2026, Edesa Biotech (EDSA) has a market capitalization of $28.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.19M

Loss-making

Shares outstanding

9,641,031

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #362Rockwell MedicalRMTI$30.8M
  2. #363Lite StrategyLITS$30.0M
  3. #364Edesa BiotechEDSA$28.9M
  4. #365BriaCell TherapeuticsBCTX$28.7M
  5. #366Incannex HealthcareIXHL$28.6M

What if Edesa Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,091,044

Per share 977,123× higher

Bitcoin $1.53T

$113,142.73

Per share 52,870× higher

Apple $5.02T

$371,437.02

Per share 173,569× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Edesa Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.